Form 8K BioNexus Gene Lab Corp. For: 17 March
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
BioNexus Gene Lab Corp (BGLC)
BioNexus Gene Lab Corp stock price live, this page displays NASDAQ BGLC stock exchange data. View the BGLC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the BioNexus Gene Lab Corp real time stock price chart below.
What Is the BioNexus Gene Lab Corp Stock Price Today?
The BioNexus Gene Lab Corp stock price today is 1.3600.
What Is the Stock Symbol for BioNexus Gene Lab Corp?
The stock symbol for BioNexus Gene Lab Corp is "BGLC."
What Stock Exchange Does BioNexus Gene Lab Corp Trade On?
BioNexus Gene Lab Corp is listed and trades on the NASDAQ stock exchange.
Is BioNexus Gene Lab Corp a Good Stock to Buy?
Determining whether BioNexus Gene Lab Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BGLC quote. (ISIN: US0906283066)
What Is the BioNexus Gene Lab Corp Stock Price Today?
The BioNexus Gene Lab Corp stock price today is 1.3600.
What Is the Stock Symbol for BioNexus Gene Lab Corp?
The stock symbol for BioNexus Gene Lab Corp is "BGLC."
What Stock Exchange Does BioNexus Gene Lab Corp Trade On?
BioNexus Gene Lab Corp is listed and trades on the NASDAQ stock exchange.
Is BioNexus Gene Lab Corp a Good Stock to Buy?
Determining whether BioNexus Gene Lab Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BGLC quote. (ISIN: US0906283066)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.2800
1.3800
52 wk Range
1.0700
7.2100
BGLC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.28001.3800
52 wk Range
1.07007.2100
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BGLC Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Form 8K BioNexus Gene Lab Corp. For: 30 December- Investing.com
- Form 8K BioNexus Gene Lab Corp. For: 17 March
- Investing.com
Form 8K BioNexus Gene Lab Corp. For: 23 February- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Earnings
Latest Release
May 15, 2026
EPS / Forecast
-0.22 / --
Revenue / Forecast
22.84K / --
Compare BGLC to Peers and Sector
Metrics to compare | BGLC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBGLCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.1x | −22.7x | 12.2x | |
PEG Ratio | 0.05 | 0.00 | 0.03 | |
Price/Book | 0.4x | 1.6x | 1.4x | |
Price / LTM Sales | 0.6x | 1.1x | 1.2x | |
Upside (Analyst Target) | - | 18.8% | 29.2% | |
Fair Value Upside | Unlock | 6.3% | 9.5% | Unlock |
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company’s products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the BioNexus Gene Lab (BGLC) Stock Price Today?
The BioNexus Gene Lab stock price today is 1.3600 USD.
What Stock Exchange Does BioNexus Gene Lab Trade On?
BioNexus Gene Lab is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for BioNexus Gene Lab?
The stock symbol for BioNexus Gene Lab is "BGLC."
What Is the BioNexus Gene Lab Market Cap?
As of today, BioNexus Gene Lab market cap is 3.2900M USD.
What Is BioNexus Gene Lab's Earnings Per Share (TTM)?
The BioNexus Gene Lab EPS (TTM) is -1.4439.
From a Technical Analysis Perspective, Is BGLC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has BioNexus Gene Lab Stock Split?
BioNexus Gene Lab has split 2 times.
How Many Employees Does BioNexus Gene Lab Have?
BioNexus Gene Lab has 19 employees.
What is the current trading status of BioNexus Gene Lab (BGLC)?
As of Jul 30, 2026, BioNexus Gene Lab (BGLC) is trading at a price of 1.3600 USD, with a previous close of 1.3600 USD. The stock has fluctuated within a day range of 1.2800 USD to 1.3800 USD, while its 52-week range spans from 1.0700 USD to 7.2100 USD.
What Is the BGLC After Hours Price?
BGLC's last after hours stock price is 1.2982 USD, the stock has decreased by -0.0618, or -4.5400%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.